An impact and cost-effectiveness analysis of rotavirus vaccine introduction in Egypt
Rotavirus vaccination could prevent a substantial number of RVGE cases, visits, hospitalizations and deaths in children. To be considered a cost-effective use of government health spending, the vaccine price would need to be reduced and/or lower health system delivery cost assumptions would need to be justified.
Authors
- Wael Khairy (ORCID: https://orcid.org/0000-0003-2260-1790)
- Andrew Clark (ORCID: https://orcid.org/0000-0003-4666-5991)
- Samy M. Abdelhamid (ORCID: https://orcid.org/0000-0003-4420-2731)
- Ahmed Zaghlol
- Marwa A. Kamel (ORCID: https://orcid.org/0000-0002-2112-0525)
- Frédéric Debellut (ORCID: https://orcid.org/0000-0002-3027-2838)
- Ali G. AL Karim
- Mohammed Rashed (ORCID: https://orcid.org/0009-0009-6259-7985)
- Mohamed N. F. Shaheen
Institutions
- Cairo University (EG)
- Heliopolis University (EG)
- London School of Hygiene & Tropical Medicine (GB)
- National Research Centre (EG)
- Ministry of Health and Population (EG)
Publication Details
- Journal
- Vaccine
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1016/j.vaccine.2025.128010
- Primary Topic
- Viral gastroenteritis research and epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00